Aptevo Therapeutics Stock Price - APVO

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 0.58 ▼ -0.01 (-1.79%)
Company Name Stock Ticker Symbol Market Type
Aptevo Therapeutics Inc APVO NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0258 -4.21% 0.5865 0.618 0.57 0.6119 0.6123 17:59:41
Bid Price Ask Price Spread Spread % News
0.576 0.5999 0.0239 3.98% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
997 321,137 $ 0.5852758 $ 187,954 354,386 0.49 - 2.15
Last Trade Time Type Quantity Stock Price Currency
19:13:19 formt 100 $ 0.576 USD

Aptevo Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 26.56M 45.28M $ -53.69M -2.39 - 43.06M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 6.00 9.80%

more financials information »

Aptevo Therapeutics News

Loading Messages....

Latest APVO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical APVO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.650.750.570.6108224262,922-0.0635-9.77%
1 Month0.61780.800.53250.6216771225,128-0.0313-5.07%
3 Months0.670.800.5130.6157292320,548-0.0835-12.46%
6 Months0.82991.040.490.7655535443,910-0.2434-29.33%
1 Year2.152.150.490.8448484471,348-1.56-72.72%
3 Years1.956.350.491.90319,052-1.36-69.92%
5 Years8.0050.000.492.00323,355-7.41-92.67%

Aptevo Therapeutics Description

Aptevo Therapeutics Inc is a biosciences company. The company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics. Its pipeline product includes Otlertuzumab, APVO414, ROR1 Candidate, Multiple ADAPTIR Candidates, ALG.APV-527, APVO436 and APVO210.

Your Recent History
Aptevo The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.